Life Science Tools & Technologies
Great healthcare starts with great science.
Universities and research labs are continuously pushing the edge in core areas such as genomics, proteomics, cellular/functional biology and providing innovation with the design of new medical devices and therapies. The life sciences tools & technologies sector, however, is a highly complex market and a particularly challenging one to compete in due to its shifting structure and changing constituent players. At Scientia, we keep up with the latest trends and breakthroughs, and help you position your company for sustainable and profitable growth.
Industry Briefings
September 01, 2011
Sequencing Trends Worth Watching: Commercial Potential of Technology Demands that Industry and Investors Alike Stay Up to Date
Brian Clancy and Harry Glorikian
May 15, 2011
Demand Escalates for iPSC Life Science Tools: Induced Pluripotent Stem Cells Prove Invaluable in Toxicity and Drug Efficacy Screening
Lisa Carey and Michael Tapella
November 01, 2010
Regen Medicine Prepares for Growth Spurt - Novel Business Models, Emerging Players, and
Transformative Products Starting to Have Impact
Arshad Ahmed, Michael Tapella
Industry Reviews
October 20, 2009
Cell Biology, Changing Research and Discovery:
How the increasing need for biological relevance is driving growth
September 18, 2008
Scientia Panelists Decentralization of Healthcare Presentation
December 17, 2007
Life Science Tools and Technologies Review
Scientia in the News
February 10, 2012
Pharmalot interview with Jonathan Pan on Biosimilar Guidance
February 02, 2012
GEN quotes Harry Glorikian in article: "Collaborations Hold the Potential to Reinvent Drug Development"
November 22, 2011
GEN quotes Harry Glorikian in article "Product and Service Firms Challenged by Uncertain NIH Funding, Polarization of Sequencing"
Press Releases
February 06, 2012
Scientia Advisors Announces Meghan Needham as Director of Marketing
January 31, 2012
Scientia Advisors Announces Rick Lifsitz has joined the firm as a Principal
January 23, 2012
Joslin Diabetes Center and Scientia Advisors Announce Strategic Marketing Agreement
Scientia Leaders »
Harry Glorikian »
Founder and Managing Partner
Arshad Ahmed »
Founding Partner
Patrick Terry »
Principal
Upcoming Conferences
May 29, 2012
Patrick Terry Speaking at Genome-wide Partnering & Dealmaking Conference
CONSULTING CAPABILITIES »
Scientia Advisors consulting capabilities are the result of the skills and expertise of highly talented individuals who have years of experience in the life science and healthcare industries.
SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
